These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 15979599)

  • 41. Mutations in the genes KCND2 and KCND3 encoding the ion channels Kv4.2 and Kv4.3, conducting the cardiac fast transient outward current (ITO,f), are not a frequent cause of long QT syndrome.
    Frank-Hansen R; Larsen LA; Andersen P; Jespersgaard C; Christiansen M
    Clin Chim Acta; 2005 Jan; 351(1-2):95-100. PubMed ID: 15563876
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation and Management of Athletes With Long QT Syndrome.
    Gomez AT; Prutkin JM; Rao AL
    Sports Health; 2016; 8(6):527-535. PubMed ID: 27480102
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.
    Daubert JP; Zareba W; Rosero SZ; Budzikowski A; Robinson JL; Moss AJ
    Am Heart J; 2007 Apr; 153(4 Suppl):53-8. PubMed ID: 17394903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
    Milberg P; Reinsch N; Osada N; Wasmer K; Mönnig G; Stypmann J; Breithardt G; Haverkamp W; Eckardt L
    Basic Res Cardiol; 2005 Jul; 100(4):365-71. PubMed ID: 15944809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ratio of late to early T-wave peak amplitude in 24-h electrocardiographic recordings as indicator of symptom history in patients with long-QT Syndrome types 1 and 2.
    Viitasalo M; Oikarinen L; Swan H; Glatter KA; Väänänen H; Fodstad H; Chiamvimonvat N; Kontula K; Toivonen L; Scheinman MM
    J Am Coll Cardiol; 2006 Jan; 47(1):112-20. PubMed ID: 16386673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [From gene to disease; ion channel proteins and the long QT syndrome].
    Wilde AA; van Langen IM
    Ned Tijdschr Geneeskd; 2000 Nov; 144(46):2205-7. PubMed ID: 11103258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic and clinical advances in congenital long QT syndrome.
    Mizusawa Y; Horie M; Wilde AA
    Circ J; 2014; 78(12):2827-33. PubMed ID: 25274057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of abnormal trafficking of KCNE1 in long QT syndrome 5.
    Harmer SC; Tinker A
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1074-6. PubMed ID: 17956282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome.
    Schwartz PJ; Priori SG; Cerrone M; Spazzolini C; Odero A; Napolitano C; Bloise R; De Ferrari GM; Klersy C; Moss AJ; Zareba W; Robinson JL; Hall WJ; Brink PA; Toivonen L; Epstein AE; Li C; Hu D
    Circulation; 2004 Apr; 109(15):1826-33. PubMed ID: 15051644
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long QT syndrome in children in the era of implantable defibrillators.
    Etheridge SP; Sanatani S; Cohen MI; Albaro CA; Saarel EV; Bradley DJ
    J Am Coll Cardiol; 2007 Oct; 50(14):1335-40. PubMed ID: 17903632
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of long QT syndrome.
    Schwartz PJ
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):346-51. PubMed ID: 16265560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Long QT syndrome--genes, mechanisms and risks. Indication for genetic family screening?].
    Bundgaard H; Havndrup O; Christiansen M; Andersen PS; Jensen HK; Svendsen JH; Kjeldsen KP
    Ugeskr Laeger; 2006 Jun; 168(26-32):2537-42. PubMed ID: 16824406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
    Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
    Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Failure of antiarrhythmia agents and understanding the phenomenon of proarrhythmia].
    Semrád B
    Vnitr Lek; 2003 Sep; 49(9):700-6. PubMed ID: 14584417
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Age- and genotype-specific triggers for life-threatening arrhythmia in the genotyped long QT syndrome.
    Sakaguchi T; Shimizu W; Itoh H; Noda T; Miyamoto Y; Nagaoka I; Oka Y; Ashihara T; Ito M; Tsuji K; Ohno S; Makiyama T; Kamakura S; Horie M
    J Cardiovasc Electrophysiol; 2008 Aug; 19(8):794-9. PubMed ID: 18373596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of Pregnancy in Patients With Congenital Long QT Syndrome.
    Garg L; Garg J; Krishnamoorthy P; Ahnert A; Shah N; Dusaj RS; Bozorgnia B
    Cardiol Rev; 2017; 25(4):197-201. PubMed ID: 27054604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and genetical aspects of the long QT syndrome.
    Wollnik B; Guicheney P
    Herz; 1994 Apr; 19(2):126-32. PubMed ID: 8194833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Congenital long QT syndromes].
    Le Marec H; Schott JJ
    Arch Mal Coeur Vaiss; 1997 Jun; 90 Spec No 3():25-35. PubMed ID: 9295920
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long QT syndrome revisited.
    Naik A
    J Assoc Physicians India; 2007 Apr; 55 Suppl():58-61. PubMed ID: 18368869
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical management of patients with the long QT syndrome: drugs, devices, and gene-specific therapy.
    Moss AJ
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2058-60. PubMed ID: 9272508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.